Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Barr Pharmaceuticals has announced that its subsidiary, Pliva - Lachema, has received final approval from the FDA for its generic version of Pfizer's Aredia injection, 30mg/ml, 60mg/ml, and 90mg/ml.
Subscribe to our email newsletter
The company plans to launch its product in the fourth quarter of calendar 2008. With this approval, Barr’s US generic injectable portfolio now totals eight products.